I support MedTech, pharma, and biotech teams with rigorous fact-checking, consistency review, and quality assurance for regulatory and clinical documents, helping ensure that claims, evidence, data, and source references are accurate, traceable, and submission-ready.
Regulatory writing is shaped by many small but consequential checks: whether a claim matches the source, whether data are transferred accurately, whether terminology stays consistent, and whether conclusions remain within the evidence. When these checks are rushed, informal, or undocumented, small errors can weaken the credibility of CERs, clinical summaries, protocols, regulatory responses, and submission materials. I help MedTech, pharma, and biotech teams strengthen fact-checking and QA workflows so evidence, claims, references, and document logic remain accurate, traceable, and review-ready.
Quality issues in regulatory writing are rarely caused by one obvious mistake. They usually appear across evidence, claims, references, data transfer, terminology, and document logic.
Sometimes the issue is a source that does not fully support the claim. Sometimes it is a copied number, table value, or endpoint that has shifted between documents. Sometimes the wording is too strong for the evidence. In other cases, inconsistencies between a CER, clinical summary, risk document, IFU, protocol, or submission response only become visible during review.
What regulatory, clinical, and medical writing teams often recognize immediately is this: the problem is not just grammar or formatting. It is whether the document remains evidence-aligned, internally consistent, and defensible.
Common signals include:
Claims that are stronger than the supporting evidence
References that do not fully match the sentence they support
Inconsistent terminology across related documents
Data, endpoints, dates, or study details interpreted partially
Missing links between clinical evidence, risk rationale, and conclusions
Conclusions that drift beyond the available data
These are not surface-level writing issues. They are quality and credibility risks that can affect review readiness, audit readiness, and confidence in the final document.
Confirming that cited sources explicitly support the stated claim.
Ensuring conclusions reflect what the evidence actually allows.
Treating evidence checking as an ongoing reasoning loop.
Weighing convergent and divergent findings without bias.
Making assumptions, trade-offs, and uncertainty visible in writing.
Adjusting claims and framing when evidence is mixed or conditional.
MedTech, pharma, and biotech teams typically bring me in when regulatory or clinical documents are moving closer to internal review, client review, audit, or submission.
At this stage, the issue is rarely just writing style. The higher-stakes concern is whether claims, evidence, references, data, terminology, and conclusions still align cleanly across the document.
My role is to provide fact-checking and QA support that helps teams catch evidence gaps, data-transfer errors, overstatements, inconsistencies, and AI-assisted accuracy risks before they become review problems.
As part of this service, AI-assisted fact-checking and critical thinking is treated as material that still requires human verification, not as a substitute for regulatory judgment.
The goal is to help MedTech, pharma, and biotech teams produce regulatory and clinical writing where evidence, claims, data, and conclusions are aligned in ways that reviewers, auditors, and internal stakeholders can readily follow.